<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34806049</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-1667</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>STAR protocols</Title><ISOAbbreviation>STAR Protoc</ISOAbbreviation></Journal><ArticleTitle>Simulating coxsackievirus B3 infection with an accessible computational model of its complete kinetics.</ArticleTitle><Pagination><StartPage>100940</StartPage><MedlinePgn>100940</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100940</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xpro.2021.100940</ELocationID><Abstract><AbstractText>We describe how to use a publicly available computational model for coxsackievirus B3 (CVB3) infection that we recast as a graphical user interface (GUI). The GUI-based implementation enables non-computationalists to incorporate systems-biology modeling into their research and teaching. The model simulates the full life cycle of CVB3, including the host antiviral response, and includes 44 alterable parameters. The model simplifies some viral life cycle processes to improve interpretability and utility when performing <i>in silico</i> experiments. For complete details on the use and execution of this protocol, please refer to Lopacinski et al. (2021).</AbstractText><CopyrightInformation>© 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Cameron D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweatt</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janes</LastName><ForeName>Kevin A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 HL007284</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>STAR Protoc</MedlineTA><NlmUniqueID>101769501</NlmUniqueID><ISSNLinking>2666-1667</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049490" MajorTopicYN="N">Systems Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="Y">User-Computer Interface</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Computer sciences</Keyword><Keyword MajorTopicYN="N">Microbiology</Keyword><Keyword MajorTopicYN="N">Systems biology</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>22</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34806049</ArticleId><ArticleId IdType="pmc">PMC8585652</ArticleId><ArticleId IdType="doi">10.1016/j.xpro.2021.100940</ArticleId><ArticleId IdType="pii">S2666-1667(21)00646-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., Randall R.E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U S A. 2004;101:17264–17269. doi: 10.1073/pnas.0407639101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0407639101</ArticleId><ArticleId IdType="pmc">PMC535396</ArticleId><ArticleId IdType="pubmed">15563593</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320–1323. doi: 10.1126/science.275.5304.1320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.275.5304.1320</ArticleId><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruggeman F.J., Westerhoff H.V. The nature of systems biology. Trends Microbiol. 2007;15:45–50. doi: 10.1016/j.tim.2006.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2006.11.003</ArticleId><ArticleId IdType="pubmed">17113776</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C.B., Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell. 2006;124:119–131. doi: 10.1016/j.cell.2005.10.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.10.035</ArticleId><ArticleId IdType="pubmed">16413486</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunnebacke T.H., Reaume M.B. Correlation of the yield of poliovirus with the size of isolated tissue cultured cells. Virology. 1958;6:8–13. doi: 10.1016/0042-6822(58)90055-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(58)90055-2</ArticleId><ArticleId IdType="pubmed">13581512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis E.L., Delbrück M. The growth OF bacteriophage. J. Gen. Physiol. 1939;22:365–384. doi: 10.1085/jgp.22.3.365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1085/jgp.22.3.365</ArticleId><ArticleId IdType="pmc">PMC2141994</ArticleId><ArticleId IdType="pubmed">19873108</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchison D., Milburn S.C., Edery I., Sonenberg N., Hershey J.W. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 1982;257:14806–14810.</Citation><ArticleIdList><ArticleId IdType="pubmed">6294080</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M.A., Lork M., Nguyen M., Hato S.V., Lanke K., Emdad L., Bhoopathi P., Fisher P.B., Lloyd R.E., van Kuppeveld F.J.M. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014;88:3369–3378. doi: 10.1128/JVI.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh K.C.M., Tang C.K., Norton D.C., Gan E.S., Tan H.C., Sun B., Syenina A., Yousuf A., Ong X.M., Kamaraj U.S., et al. Molecular determinants of plaque size as an indicator of dengue virus attenuation. Sci. Rep. 2016;6:26100. doi: 10.1038/srep26100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26100</ArticleId><ArticleId IdType="pmc">PMC4868997</ArticleId><ArticleId IdType="pubmed">27185466</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P., Liu Y., Ma H.-C., Paul A.V., Wimmer E. Picornavirus morphogenesis. Microbiol. Mol. Biol. Rev. 2014;78:418–437. doi: 10.1128/MMBR.00012-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00012-14</ArticleId><ArticleId IdType="pmc">PMC4187686</ArticleId><ArticleId IdType="pubmed">25184560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., Fisher P.B. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U S A. 2002;99:637–642. doi: 10.1073/pnas.022637199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.022637199</ArticleId><ArticleId IdType="pmc">PMC117358</ArticleId><ArticleId IdType="pubmed">11805321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005;6:981–988. doi: 10.1038/ni1243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1243</ArticleId><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf B.J., Barton D.J. Poliovirus 2A(Pro) increases viral mRNA and polysome stability coordinately in time with cleavage of eIF4G. J. Virol. 2008;82:5847–5859. doi: 10.1128/JVI.01514-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01514-07</ArticleId><ArticleId IdType="pmc">PMC2395153</ArticleId><ArticleId IdType="pubmed">18400852</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopacinski A.B., Sweatt A.J., Smolko C.M., Gray-Gaillard E., Borgman C.A., Shah M., Janes K.A. Modeling the complete kinetics of coxsackievirus B3 reveals human determinants of host-cell feedback. Cell Syst. 2021;12:304–323.e13. doi: 10.1016/j.cels.2021.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2021.02.004</ArticleId><ArticleId IdType="pmc">PMC8112228</ArticleId><ArticleId IdType="pubmed">33740397</ArticleId></ArticleIdList></Reference><Reference><Citation>Melia C.E., Peddie C.J., de Jong A.W.M., Snijder E.J., Collinson L.M., Koster A.J., van der Schaar H.M., van Kuppeveld F.J.M., Bárcena M. Origins of enterovirus replication organelles established by whole-cell electron microscopy. mBio. 2019;10 doi: 10.1128/mBio.00951-19. e00951–19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00951-19</ArticleId><ArticleId IdType="pmc">PMC6561026</ArticleId><ArticleId IdType="pubmed">31186324</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S., Krijnse-Locker J. Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 2008;6:363–374. doi: 10.1038/nrmicro1890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1890</ArticleId><ArticleId IdType="pmc">PMC7096853</ArticleId><ArticleId IdType="pubmed">18414501</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A., Morosky S.A., Delorme-Axford E., Dybdahl-Sissoko N., Oberste M.S., Wang T., Coyne C.B. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011;7:e1001311. doi: 10.1371/journal.ppat.1001311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello V. In: Fields Virology. Knipe D.M., Howley P.M., editors. Wolters Kluwer/Lippincott Williams &amp; Wilkins Health; 2013. Picornaviridae: the viruses and their replication; pp. 452–489.</Citation></Reference><Reference><Citation>Sadler A.J., Williams B.R.G. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008;8:559–568. doi: 10.1038/nri2314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2314</ArticleId><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth R.B., Sun L., Ea C.-K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122:669–682. doi: 10.1016/j.cell.2005.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., Barry R.D. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 1995;69:3873–3877. doi: 10.1128/JVI.69.6.3873-3877.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.6.3873-3877.1995</ArticleId><ArticleId IdType="pmc">PMC189108</ArticleId><ArticleId IdType="pubmed">7538177</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden L., Vives-Adrián L., Selisko B., Ferrer-Orta C., Liu X., Lanke K., Ulferts R., De Palma A.M., Tanchis F., Goris N., et al. The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family. PLoS Pathog. 2015;11:e1004733. doi: 10.1371/journal.ppat.1004733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004733</ArticleId><ArticleId IdType="pmc">PMC4370873</ArticleId><ArticleId IdType="pubmed">25799064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Li R., Shu B., Jing X., Ye H.-Q., Gong P. Stringent control of the RNA-dependent RNA polymerase translocation revealed by multiple intermediate structures. Nat. Commun. 2020;11:2605. doi: 10.1038/s41467-020-16234-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16234-4</ArticleId><ArticleId IdType="pmc">PMC7248106</ArticleId><ArticleId IdType="pubmed">32451382</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang W., Cuconati A., Hope D., Kirkegaard K., Wimmer E. Complete protein linkage map of poliovirus P3 proteins: interaction of polymerase 3Dpol with VPg and with genetic variants of 3AB. J. Virol. 1998;72:6732–6741. doi: 10.1128/JVI.72.8.6732-6741.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.8.6732-6741.1998</ArticleId><ArticleId IdType="pmc">PMC109881</ArticleId><ArticleId IdType="pubmed">9658121</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>